R&D Analysis

Nektar Therapeutics pipeline update: REZPEG clinical programs and regulatory context

atopic dermatitis · 5 min

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Data at ADA 2026

GLP-1 · 5 min

Poly Medicure appoints Indranil Mukherjee as CEO, APAC & India: Strategic implications for pharma BD teams

4 min

Cell Therapy Packaging Market Size & Share Report, 2033: Key Trends and Forecasts

cell therapy · 4 min

Orion Pharma's ODM-212 Shows Favorable Safety in Phase 1/2 TEADES Trial for Advanced Solid Tumours

advanced solid tumours · 4 min

The Pharma Choke Point: A Strategic Risk for U.S. Pharmaceutical Supply Chains

5 min

Ecosystem Over Geography: Life Sciences Location Strategy in APAC

EMA · 5 min

Helus Pharma to Participate in the Jefferies Global Healthcare Conference: Strategic Implications for Analysts and BD Teams

4 min

Acclinate and HCN Global Forge Strategic Partnership to Enhance Clinical Research Diversity

6 min

The Pulse of ACC: Honoring Eugene Braunwald and Shaping Cardiology's Future

hypertrophic cardiomyopathy · 7 min

Illumina's APAC Strategy Under Nilesh Shah: A Competitive Benchmark

7 min

How Medicine Forgot Women: A Missed Opportunity for Asia

9 min